Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
53%
Cross-Sectional Study
44%
Antibiotics
42%
Prevalence
41%
Diseases
38%
Antibiotic Resistance
34%
Antiinfective Agent
34%
Antimicrobial Agent
24%
Cross-Sectional Study
22%
Adverse Event
21%
Cohort Study
21%
Community Pharmacy
20%
Cardiovascular Disease
20%
Chronic Disease
19%
COVID-19 Vaccine
17%
Comorbidity
17%
Tablet
17%
Polypharmacy
16%
Hemoglobin A1c
14%
Gentamicin
14%
Quinolone Derivative
14%
Side Effect
14%
Randomized Controlled Trial
13%
Transcription Factor Nrf2
13%
Nanoparticle
13%
Warfarin
13%
Diabetic Cardiomyopathy
13%
FDA Adverse Event Reporting System
12%
Infection
12%
Escherichia coli
12%
Pandemic
11%
Medication Error
11%
Coronavirinae
10%
Pharmacotherapy
10%
Bacterium
10%
Hydroxychloroquine
10%
Azithromycin
10%
Cefazolin
10%
Vaccination
10%
Surgical Infection
10%
Brain Ischemia
9%
Etanercept
9%
Congestive Heart Failure
9%
Klebsiella pneumoniae
8%
Retrospective Study
8%
Clinical Trial
8%
Acinetobacter Baumannii
8%
Pseudomonas aeruginosa
8%
Adalimumab
8%
Observational Study
7%
Nursing and Health Professions
Saudi Arabia
100%
Cross-Sectional Study
44%
Prevalence
29%
Diabetes Mellitus
27%
Chronic Disease
26%
Diseases
25%
Chronic Condition
22%
Blood Pressure
21%
Cross-Sectional Study
21%
Cohort Analysis
18%
Hypertension
18%
Meta Analysis
17%
Warfarin
17%
Health Care Cost
16%
Primary Health Care
16%
Antimicrobial Stewardship
14%
COVID-19
14%
Cardiovascular Disease
13%
Telemedicine
13%
Systematic Review
13%
Health Care Personnel
13%
Medication Error
13%
Antiinfective Agent
13%
Comorbidity
12%
Polypharmacy
12%
Quality of Life
11%
Health Care
11%
Adherence
10%
Treatment Outcome
10%
Confidence Interval
10%
Patient Care
10%
Tertiary Care Center
9%
Odds Ratio
9%
Health Economics
8%
Practice Guideline
8%
Emergency Ward
8%
Patient with Hypertension
8%
Anticoagulation
7%
Patient Compliance
7%
Community Pharmacist
7%
Healthcare System
6%
Antimicrobial Resistance
6%
Cost Effectiveness Analysis
6%
Quality of Life
6%
World Health Organization
6%
Congestive Heart Failure
6%
Systolic Blood Pressure
6%
Cost Control
6%
Perioperative
6%
Surgical Infection
6%
Medicine and Dentistry
Health Care Cost
35%
COVID-19
25%
Diabetes Mellitus
22%
Hypertension
12%
Diseases
11%
Diabetes
10%
Systematic Review
10%
Blood Pressure
9%
Cross Sectional Study
8%
Retrospective Cohort Study
8%
Tertiary Care
7%
Quality Adjusted Life Year
7%
Quinolone Derivative
6%
Drug Resistant Tuberculosis
6%
Sputum Smear
6%
Systolic Blood Pressure
6%
Emergency Department
6%
Female Genital Tract Cancer
6%
Patient with Hypertension
6%
Percutaneous Thrombectomy
6%
Brain Ischemia
6%
Comorbidity
6%
Prevalence
5%
Cardiovascular Disease
5%
Lifespan
5%
Rare Disease
5%
Health Care
5%